Found 6 matching trials
Phase II Study of Clofarabine in Pediatric Acute Lymphoblastic Leukemia (ALL)
PHASE2Clofarabine (injection) is approved by the Food and Drug Administration (FD...
Location
Children's Hospital
Phase II Study of Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia
PHASE2Clofarabine (injection) is approved by the Food and Drug Administration (FD...
Location
Multiple Locations
Clofarabine in Adult Patients With Advanced Solid Tumors
PHASE1Clofarabine (injection) is approved by the Food and Drug Administration (FD...
Location
Mary Crowley Medical Research Center
A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I)
PHASE3Clofarabine (injection) is approved by the Food and Drug Administration (FD...
Location
Mayo Clinical Hospital
Phase II Study of Clofarabine in Pediatric Acute Myelogenous Leukemia (AML) Patients
PHASE2Clofarabine (injection) is approved by the Food and Drug Administration (FD...
Location
Arkansas Children's Hospital
Clofarabine in High Risk Myelodysplastic Syndrome (MDS)
PHASE1This study aims to determine the maximal tolerated dose (MTD) and dose limi...